Effect of intestinal resection on quality of life in Crohn's disease
Journal article
Wright, Emily K., Kamm, Michael A., De Cruz, Peter, Hamilton, Amy L., Ritchie, Kathryn J., Krejany, Efrosinia O., Gorelik, Alexandra, Liew, Danny, Prideaux, Lani, Lawrance, Ian C., Andrews, Jane M., Bampton, Peter A., Sparrow, Miles P., Florin, Timothy H., Gibson, Peter R., Debinski, Henry, Gearry, Richard B., Macrae, Finlay A., Leong, Rupert W., ... Desmond, Paul V.. (2015). Effect of intestinal resection on quality of life in Crohn's disease. Journal of Crohn's and Colitis. 9(6), pp. 452 - 462. https://doi.org/10.1093/ecco-jcc/jjv058
Authors | Wright, Emily K., Kamm, Michael A., De Cruz, Peter, Hamilton, Amy L., Ritchie, Kathryn J., Krejany, Efrosinia O., Gorelik, Alexandra, Liew, Danny, Prideaux, Lani, Lawrance, Ian C., Andrews, Jane M., Bampton, Peter A., Sparrow, Miles P., Florin, Timothy H., Gibson, Peter R., Debinski, Henry, Gearry, Richard B., Macrae, Finlay A., Leong, Rupert W., Kronborg, Ian, Radford-Smith, Graham, Selby, Warwick, Johnston, Michael J., Woods, Rodney, Elliott, P. Ross, Bell, Sally J., Brown, Steven J., Connell, William R. and Desmond, Paul V. |
---|---|
Abstract | Introduction: Patients with Crohn’s disease have poorer health-related quality of life [HRQoL] than healthy individuals, even when in remission. Although HRQoL improves in patients who achieve drug-induced or surgically induced remission, the effects of surgery overall have not been well characterised. Methods: In a randomised trial, patients undergoing intestinal resection of all macroscopically diseased bowel were treated with postoperative drug therapy to prevent disease recurrence. All patients were followed prospectively for 18 months. C-reactive protein [CRP], Crohn’s Disease Activity Index [CDAI], and faecal calprotectin [FC] were measured preoperatively and at 6, 12, and 18 months. HRQoL was assessed with a general [SF36] and disease-specific [IBDQ] questionnaires at the same time points. Results: A total of 174 patients were included. HRQoL was poor preoperatively but improved significantly [p < 0.001] at 6 months postoperatively. This improvement was sustained at 18 months. Females and smokers had a poorer HRQoL when compared with males and non-smokers, respectively. Persistent endoscopic remission, intensification of drug treatment at 6 months, and anti-tumour necrosis factor therapy were not associated with HRQoL outcomes different from those when these factors were not present. There was a significant inverse correlation between CDAI, [but not endoscopic recurrence, CRP, or FC] on HRQoL. Conclusion: Intestinal resection of all macroscopic Crohn’s disease in patients treated with postoperative prophylactic drug therapy is associated with significant and sustained improvement in HRQoL irrespective of type of drug treatment or endoscopic recurrence. HRQoL is lower in female patients and smokers. A higher CDAI, but not direct measures of active disease or type of drug therapy, is associated with a lower HRQoL. |
Keywords | Crohn’s disease; inflammatory bowel disease; postoperative; health-related quality of life; biologicals; smoking |
Year | 2015 |
Journal | Journal of Crohn's and Colitis |
Journal citation | 9 (6), pp. 452 - 462 |
Publisher | Oxford University Press |
ISSN | 1873-9946 |
Digital Object Identifier (DOI) | https://doi.org/10.1093/ecco-jcc/jjv058 |
Scopus EID | 2-s2.0-84963741474 |
Page range | 452 - 462 |
Publisher's version | File Access Level Controlled |
Place of publication | United Kingdom |
https://acuresearchbank.acu.edu.au/item/89yxw/effect-of-intestinal-resection-on-quality-of-life-in-crohn-s-disease
Restricted files
Publisher's version
104
total views0
total downloads0
views this month0
downloads this month